Covered recipient · General Payments record
ARTHUR F PATTON
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$1,126.73
- Reported across 66 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $293.97 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $106.29 | 6 |
| Lilly USA, LLC | $64.75 | 3 |
| Exact Sciences Corporation | $41.28 | 3 |
| ABBVIE INC. | $24.12 | 1 |
| Phathom Pharmaceuticals, Inc. | $21.06 | 1 |
| DEXCOM, INC. | $20.68 | 1 |
| PFIZER INC. | $15.79 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.12 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105213181 | CMS |
| Dexcom, Inc. | $20.68 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153282840 | CMS |
| Exact Sciences Corporation | $14.07 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114828566 | CMS |
| Exact Sciences Corporation | $14.10 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114828572 | CMS |
| Exact Sciences Corporation | $13.11 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114828577 | CMS |
| Lilly USA, LLC | $23.46 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136053249 | CMS |
| Lilly USA, LLC | $20.34 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136049247 | CMS |
| Lilly USA, LLC | $20.95 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136054184 | CMS |
| Novo Nordisk Inc | $18.54 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097401507 | CMS |
| Novo Nordisk Inc | $18.57 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097050683 | CMS |
| Novo Nordisk Inc | $23.48 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096791543 | CMS |
| Novo Nordisk Inc | $14.29 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096691224 | CMS |
| Novo Nordisk Inc | $16.49 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096991095 | CMS |
| Novo Nordisk Inc | $14.92 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097692401 | CMS |
| PFIZER INC. | $15.79 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132030307 | CMS |
| Phathom Pharmaceuticals, Inc. | $21.06 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151108522 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.